Barclays’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $7K | Sell |
|
|||||
|
2024
Q3 | $56K | Sell |
|
|||||
|
2024
Q2 | $107K | Sell |
|
|||||
|
2024
Q1 | $119K | Sell |
|
|||||
|
2023
Q4 | $155K | Buy |
|
|||||
|
2023
Q3 | $168K | Sell |
|
|||||
|
2023
Q2 | $490K | Buy |
|
|||||
|
2023
Q1 | $158K | Sell |
|
|||||
|
2022
Q4 | $1M | Sell |
|
|||||
|
2022
Q3 | $1.03M | Buy |
|
|||||
|
2022
Q2 | $153K | Sell |
|
|||||
|
2022
Q1 | $455K | Sell |
|
|||||
|
2021
Q4 | $759K | Buy |
|
|||||
|
2021
Q3 | $657K | Buy |
|
|||||
|
2021
Q2 | $273K | Sell |
|
|||||
|
2021
Q1 | $998K | Sell |
|
|||||
|
2020
Q4 | $1.19M | Sell |
|
|||||
|
2020
Q3 | $1.2M | Buy |
|
|||||
|
2020
Q2 | $659K | Sell |
|
|||||
|
2020
Q1 | $1.75M | Buy |
|
|||||
|
2019
Q4 | $1.3M | Sell |
|
|||||
|
2019
Q3 | $2.01M | Buy |
|
|||||
|
2019
Q2 | $1.71M | Buy |
|
|||||
|
2019
Q1 | $1.37M | Buy |
|
|||||
|
2018
Q4 | $852K | Sell |
|
|||||
|
2018
Q3 | $1.95M | Buy |
|
|||||
|
2018
Q2 | $817K | Buy |
|
|||||
|
2018
Q1 | $238K | Sell |
|
|||||
|
2017
Q4 | $976K | Buy |
|
|||||
|
2017
Q3 | $60K | Sell |
|
|||||
|
2017
Q2 | $2.33M | Sell |
|
|||||
|
2017
Q1 | $3.69M | Buy |
|
|||||
|
2016
Q4 | $2.68M | Sell |
|
|||||
|
2016
Q3 | $4.53M | Buy |
|
|||||
|
2016
Q2 | $77K | Sell |
|
|||||
|
2016
Q1 | $95K | Sell |
|
|||||
|
2015
Q4 | $238K | Buy |
|
|||||
|
2015
Q3 | $19K | Buy |
|
|||||
|
2015
Q2 | $13K | Sell |
|
|||||
|
2015
Q1 | $820K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $1K | Sell |
|
|||||
|
2014
Q2 | $128K | Buy |
|
|||||
|
2014
Q1 | $1K | Buy |
|